Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0% · short 5.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for INTERPHARM HOLDINGS INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
20 buys97 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | Award | $206K | SEC |
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | Award | $206.6K | SEC |
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | Award | $205.9K | SEC |
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | Award | $205.9K | SEC |
| Dickerson Thomas | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | Award | $78.2K | SEC |
| SUTARIA MAGANLAtrack record | Buy | $2.3K | conv 51First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $304 | conv 50First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $1.5K | conv 50First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $10K | conv 52First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $3.9K | conv 51First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $10K | conv 52First in 12mo | SEC |
| SUTARIA MAGANLAtrack record | Buy | $2.2K | conv 51First in 12mo | SEC |
| Weiss Jeffrey A | Buy | $21.4K | conv 78First in 12mo | SEC |
| Cappel Kenneth | AwardD (derivative) | $23.5K | SEC |
| Weiss Jeffrey A | AwardD (derivative) | $28.8K | SEC |
| Cappel Kenneth | AwardD (derivative) | $23.5K | SEC |
| Weiss Jeffrey A | AwardD (derivative) | $28.8K | SEC |
| Cappel Kenneth | AwardD (derivative) | $23.5K | SEC |
| Weiss Jeffrey A | Buy | $22.5K | conv 51 | SEC |